Spyre Therapeutics, Inc. was listed on Nasdaq and received analyst ratings from firms including Deutsche Bank and Stifel.

The entities involved

• Deutsche Bank →

  German global banking and financial services company

  • Geopolitical risk adds to UK fiscal pressures as renewed fighting drives up oil prices, prompting economists to analyze market impacts.Mon 15:09
  • Bank of America upgraded a rating to buy and suggested a potential equity stake in a Caribbean resort chain, supported by Deutsche Bank.Mon 13:32
• Stifel →

  American investment bank

  • China and Stifel are currently top suppliers in the critical minerals market, with their market actions showing a preference for producers located outside of China.Mon 00:03
  • AI stocks are benefiting from Trump-era tariffs, and Brian Schwartz maintained an Outperform rating on Workday on September 5th.Sun 01:33
• Nasdaq →

  American fully electronic stock exchange

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.Mon 16:28

Related events

• Stifel reiterated a Buy rating and target price for Spyre Therapeutics, while Deutsche Bank lowered targets following company results.Sep 1
• Cohu, Inc. received analyst research and price targets from TD Cowen while trading on Nasdaq, with data aggregated by MarketBeat.Aug 19
• Analyst targets are being revised to reflect market concerns regarding future earnings and fuel cost volatility for companies including Goldman Sachs, Carnival Corp., and Deutsche Bank.Mon 02:38
• MarketBeat reported analyst recommendations for AMCI Acquisition Corp., which is listed on the Nasdaq electronic stock exchange.Sep 3
• Analysts provided price targets and ratings for Ross Stores, Inc., which was traded on the Nasdaq exchange.Aug 27